Does RUXOLITINIB Cause Ecchymosis? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Ecchymosis have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
65
Reports of Ecchymosis with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
21
Deaths
43
Hospitalizations
How Dangerous Is Ecchymosis From RUXOLITINIB?
Of the 65 reports, 21 (32.3%) resulted in death, 43 (66.2%) required hospitalization, and 3 (4.6%) were considered life-threatening.
Is Ecchymosis Listed in the Official Label?
Yes, Ecchymosis is listed as a known adverse reaction in the official FDA drug label for RUXOLITINIB.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Ecchymosis?
RIVAROXABAN (398)
ASPIRIN (344)
WARFARIN (248)
CLOPIDOGREL BISULFATE (205)
IBRUTINIB (189)
APIXABAN (154)
METHOTREXATE (131)
PREDNISONE (118)
TOCILIZUMAB (92)
DABIGATRAN ETEXILATE (79)
Which RUXOLITINIB Alternatives Have Lower Ecchymosis Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE